Outlook Therapeutics (OTLK) Return on Sales (2015 - 2025)
Outlook Therapeutics (OTLK) posted quarterly Return on Sales of 1.45% for Q3 2025, up 1181.54% quarter-over-quarter from 0.13% in Q2 2025.
Outlook Therapeutics (OTLK) Return on Sales (2015 - 2025) Analysis & Trends
Outlook Therapeutics (OTLK) has reported Return on Sales for 6 consecutive years, with 1.45% the latest figure, recorded in Q3 2025.
- In Q3 2025, Return on Sales changed N/A year-over-year to 1.45%; the TTM figure through Sep 2025 stood at 0.13% (changed N/A YoY), while the FY2025 annual figure was 0.44%, changed N/A from the prior year.
- Return on Sales grew to 1.45% in Q3 2025 per OTLK's latest filing, from 0.13% in the prior quarter.
- Across five years, Return on Sales topped out at 1.45% in Q3 2025 and bottomed at 0.13% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Outlook Therapeutics | 88.50 Mn | 77.26 Mn | -8,265.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.45% |
| Jun 30, 2025 | -0.13% |
| Sep 30, 2019 | -0.02% |
| Jun 30, 2019 | -0.08% |
| Mar 31, 2019 | -0.16% |
| Dec 31, 2018 | -0.09% |
| Sep 30, 2018 | -0.16% |
| Jun 30, 2018 | -0.11% |
| Mar 31, 2018 | -0.10% |
| Dec 31, 2017 | -0.02% |
| Sep 30, 2017 | -0.02% |
| Jun 30, 2017 | -0.18% |
| Mar 31, 2017 | -0.27% |
| Dec 31, 2016 | -0.63% |
| Sep 30, 2016 | -0.21% |
| Jun 30, 2016 | -0.45% |
| Mar 31, 2016 | -0.04% |
| Dec 31, 2015 | -0.17% |
| Sep 30, 2015 | -0.36% |
| Jun 30, 2015 | -0.09% |